Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.82  0.02  0.70%   
About 61% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  

Lisata Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Lisata Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at globenewswire.com         
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
Macroaxis News: globenewswire.com
over a week ago at finance.yahoo.com         
Akoya Biosciences Third Quarter 2024 Earnings Misses Expectations
Yahoo News
over a week ago at finance.yahoo.com         
Xenetic Biosciences Third Quarter 2024 Earnings Misses Expectations
Yahoo News
over a week ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Increases Stake in Aptose Biosciences Inc
Gurufocus Stories at Macroaxis
over a week ago at seekingalpha.com         
Cellectar Biosciences Q3 2024 Earnings Preview
seekingalpha News
over a week ago at finance.yahoo.com         
Willow Biosciences Third Quarter 2024 Earnings CA0.01 loss per share
Yahoo News
over a week ago at seekingalpha.com         
Inhibrx Biosciences GAAP EPS of -2.84
seekingalpha News
over a week ago at finance.yahoo.com         
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
Yahoo News
over a week ago at finance.yahoo.com         
Akoya Biosciences Reports Third Quarter 2024 Financial Results
Yahoo News
over a week ago at investing.com         
Akoya Biosciences earnings missed, revenue fell short of estimates
Investing News at Macroaxis
over a week ago at gurufocus.com         
Senti Biosciences Inc Reports Q3 2024 Net Loss of 28.9 Million with No Revenue
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Cogent Biosciences Inc Reports Q3 2024 Net Loss Per Share of 0.64, Exceeding Analyst Estimates
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Artelo Biosciences Stock Dips Amidst Financial Report
Gurufocus Stories at Macroaxis
over two weeks ago at prnewswire.com         
Continuity Biosciences se lanza para permitir terapias innovadoras con nuevas tecnologas de administ...
prnewswire News
over two weeks ago at finance.yahoo.com         
Sparian Biosciences Announces Formation of its Science Advisory Board
Yahoo News
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Castle Biosciences Inc Trading 3.24 percent Higher on Oct 29
10/29/2024
2
Cytek Biosciences, Inc. Q3 Earnings and Revenues Beat Estimates
11/05/2024
3
Artelo Biosciences Stock Dips Amidst Financial Report
11/13/2024
4
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
11/18/2024
5
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinsons Research Through Development of Next Generation Biomarker As...
11/19/2024
6
Forte Biosciences, Inc. Announces Oversubscribed 53 Million Private Placement From Leading ...
11/20/2024
7
The Dr. James Morales Grant for Medicine and Biosciences Invites Undergraduate Scholars to Apply
11/21/2024
8
Anixa Biosciences board approves purchase of Bitcoin as treasury reserve asset
11/22/2024
9
Aptose Biosciences Inc. Announces Closing of 8 Million Public Offering
11/25/2024

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets